Pure Global
NCT05015751

Assessment of CSF Shunt Flow With Thermal Measurements A

Assessment Of Flow In Cerebrospinal Fluid Shunts With A Wireless Thermal Anisotropy Measurement Device: Phase A
Rhaeos, Inc.·ClinicalTrials.gov·device·Device trialCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Hydrocephalus
Drug/Device/Intervention
Thermal Anisotropy Measurement Device
Study type
Observational
Intervention type
device
Sponsor & location
Primary sponsor
Rhaeos, Inc.
Location
Oakland,San Francisco,Chicago,Chicago, United States of America
Timeline & enrollment
Phase
N/A
Start date
Aug 25, 2021
End date
Jul 13, 2022
Enrollment
44 participants
Primary outcome

Diagnostic Performance

Summary

This study evaluates the performance of a non-invasive thermal measurement device for
 assessing CSF shunt flow. Patients with an existing implanted shunt and symptoms of shunt
 malfunction will be evaluated with the study device.

ICD-10 classifications
HydrocephalusHydrocephalus, unspecifiedOther hydrocephalusCongenital hydrocephalusObstructive hydrocephalus
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05015751
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT05015751 through Pure Global AI's free database. This phase not specified trial is sponsored by Rhaeos, Inc. and is currently Completed. The study focuses on Hydrocephalus. Target enrollment is 44 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.